NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
9.19
+0.01 (0.11%)
Nov 20, 2024, 4:00 PM EST - Market closed
NeuroPace Employees
NeuroPace had 171 employees as of December 31, 2023. The number of employees increased by 4 or 2.40% compared to the previous year.
Employees
171
Change (1Y)
4
Growth (1Y)
2.40%
Revenue / Employee
$447,088
Profits / Employee
-$164,275
Market Cap
274.30M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 171 | 4 | 2.40% |
| Dec 31, 2022 | 167 | 1 | 0.60% |
| Dec 31, 2021 | 166 | 14 | 9.21% |
| Dec 31, 2020 | 152 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Accolade | 2,400 |
| AngioDynamics | 748 |
| Lifecore Biomedical | 524 |
| Poseida Therapeutics | 330 |
| Nautilus Biotechnology | 167 |
| Mersana Therapeutics | 123 |
| Atea Pharmaceuticals | 75 |
| Rezolute | 59 |
NPCE News
- 8 days ago - NeuroPace, Inc. (NPCE) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - NeuroPace Announces FDA Submission of Three-Year Data from Post-Approval Study of the RNS System in Focal Epilepsy - GlobeNewsWire
- 4 weeks ago - NeuroPace to Report Third Quarter 2024 Financial Results on November 12, 2024 - GlobeNewsWire
- 5 weeks ago - NeuroPace Continues to Strengthen Management Team - GlobeNewsWire
- 2 months ago - NeuroPace Strengthens Management Team with Two Key Appointments - GlobeNewsWire
- 3 months ago - NeuroPace Announces Participation at Two Upcoming Healthcare Investor Conferences - GlobeNewsWire
- 3 months ago - NeuroPace to Participate in Upcoming Healthcare Conferences in September - GlobeNewsWire
- 3 months ago - NeuroPace: Only For Those With Strong Nerves - Seeking Alpha